Searched for
GLOBAL PHARMA MNCS
“Reallocate, Diversify, Reposition”: Ajay Srivastava flags rising macro risks for investorsIndian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corpora...- When the world's an oyster for Sun (Pharma)Indian companies are increasingly making bold acquisitions abroad. Sun Pharma's deal signals a new era of deliberate empire-building. This ...
- Demand for senior technology leaders in India is bucking a slowdown in broader tech hiringAs per experts, many MNCs are considering shifting global tech positions to India, mostly to their GCCs. Ratna Gupta, senior partner, ABC C...
- US tariff chaos, global headwinds hit pharma GCC hiring in IndiaUncertainty surrounding US tariffs and global economic headwinds has tempered hiring in India's pharma and healthcare GCCs. Experts predict...
- Global companies account for 60% of Indian vaccine sales by valueIndia's vaccine market is steadily recovering after the impact from Covid-19 and multinationals are back to slowly gaining traction, sugges...
- Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...
- Patented drug launches help MNCs score over Indian peersWhile Indian companies still control almost 80% of the market in the country, the strategy of launching specialised patented product is hel...
- Panel for blanket ban on FDI in brown field pharma unitsThe committee demands caution on the issue from the government and reiterates its recommendation to impose a blanket ban in FDI in brown fi...
- Pharma MNCs run into rough weatherThe rejection of the Glivec patent has added to pharma MNCs’ woes after a slew of measures in the past one year.
- Pharma MNCs increase focus in Indian market: ICRAMulti-national pharma companies have increased their focus in the country following their rapid growth in the Indian market.
- Pharma MNCs eye Indian companies to collaborate on drugs, moleculesTo take advantage of the robust growth of the domestic pharma industry, MNCs are looking at alliances and partnerships.
- MNC pharma firms campaigning against Indian cos, says govtThe government today said multi national companies (MNCs) are campaigning against domestic pharma industry as their interests were getting ...
- FDI cap in pharma will hurt global investor confidence: OPPIImposing restrictions on FDI in the pharmaceutical sector, in the wake of MNCs acquiring domestic firms would hurt overseas investment flow...
- Pharma, healthcare grew this year on M&A booster doseThe pharma and healthcare sectors hit headlines on account of M&As, but inbound buyouts by MNCs raised concerns over availability of low-co...
- Pharma MNCs will call the shots soonForeign drugmakers are poised to regain the supremacy they ceded during the 1970s, thanks to their strategy of gobbling up India’s leading ...
- MNCs back in control of 50% of Indian pharma marketAcquisitions to help MNCs control nearly 50% of $9.5-billion domestic retail drug market: Analysts
- MNCs eye Indian pharmaAcquisitions of Indian pharma companies by large multinationals has raised fears.
- New definition of counterfeit worries drug cos, NGOsThe Indian drug industry and public health interest groups have voiced strong concerns over the new definition of counterfeit drugs that ha...
- Pfizer, Novartis and Merck test negative in IndiaPharma giants like Pfizer, Novartis and Merck have seen their market capitalisation erode over the last three years, as sales started to wi...
- Global pharma MNCs find China toughColleen Cheng and Angel Chen, Chinese marketing executives in their 30s, should be the ideal customers for US and European drugmakers.
Load More
